Skip to main content
OpenTrials

Clinical trial condition

Neoplasm, Residual

Explore clinical trials studying Neoplasm, Residual. Study availability and eligibility vary by location and protocol.

207 public trials 79 recruiting studies
Refine in advanced search Browse all conditions

Neoplasm, Residual trial results

Completed

Phase II Study of the BiTE® Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor Acute Lymphoblastic Leukemia (ALL)

NCT00560794

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
Locations
  • Universitätsklinikum Ulm Ulm, Baden-Wurttemberg, Germany
  • Julius-Maximilians-Universität Würzburg Würzburg, Bavaria, Germany
  • Klinikum der J.W. Goethe Universität Frankfurt am Main, Hesse, Germany
  • Universitätsklinikum Münster Münster, North Rhine-Westphalia, Germany
View Trial Details
Completed

Intrathecal DepoCyte and Lineage-targeted Minimal Residual Disease-oriented Therapy of Acute Lymphoblastic Leukemia

NCT00795756

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
Locations
  • USC Ematologia, Ospedale Civile Alessandria, (al), Italy
  • USC Ematologia, Ospedali Riuniti Bergamo, (bg), Italy
  • Divisione di Ematologia - Spedali Civili Brescia, (bs), Italy
  • Divisione di Ematologia e TMO, Ospedale San Maurizio Bolzano, (bz), Italy
View all 16 locations
View Trial Details
Completed

Treatment of Adult ALL With an MRD-directed Programme.

NCT00358072

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
Locations
  • Ospedali Riuniti di Bergamo Bergamo, BG, Italy
  • Divisione Ematologia Spedali Civili Brescia, BS, Italy
  • Divisione di Ematologia e TMO Ospedale San Maurizio Bolzano, BZ, Italy
  • U.O. Ematologia e Centro TMO Ospedale Armando Businco Cagliari, CA, Italy
View all 15 locations
View Trial Details

Related conditions